Concourse Financial Group Securities’s Tvardi Therapeutics TVRD Stock Holding History

Concourse Financial Group Securities’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	-$33	–	2348
2024 Q3	$30	Hold	3	–	–	﹤0.01%	2227
2024 Q2	$25	Hold	3	–	–	﹤0.01%	2289
2024 Q1	$91	Hold	3	–	–	﹤0.01%	2274
2023 Q4	$74	Hold	3	–	–	﹤0.01%	2245
2023 Q3	$168	Hold	3	–	–	﹤0.01%	2257
2023 Q2	$283	Hold	3	–	–	﹤0.01%	2269
2023 Q1	$491	Hold	3	–	–	﹤0.01%	2250
2022 Q4	$1.07K	Hold	3	–	–	﹤0.01%	2157
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	1952
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	2161
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	2142
2021 Q4	$1K	Hold	3	–	–	﹤0.01%	2340
2021 Q3	$2K	Hold	3	–	–	﹤0.01%	2259
2021 Q2	$1K	Hold	3	–	–	﹤0.01%	2329
2021 Q1	$2K	Hold	3	–	–	﹤0.01%	2176
2020 Q4	$2K	Hold	3	–	–	﹤0.01%	2134
2020 Q3	$1K	Hold	3	–	–	﹤0.01%	2127
2020 Q2	$2K	Hold	3	–	–	﹤0.01%	1949
2020 Q1	$1K	Hold	3	–	–	﹤0.01%	2119
2019 Q4	$2K	Buy	+3	New	+$2.1K	﹤0.01%	1942
2019 Q3	–	Sell	-3	Closed	-$2.49K	–	2188
2019 Q2	$2K	Hold	3	–	–	﹤0.01%	2047
2019 Q1	$1K	Hold	3	–	–	﹤0.01%	2200
2018 Q4	$1K	Buy	+3	New	+$1.94K	﹤0.01%	2067

Other funds holding TVRD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Concourse Financial Group Securities's TVRD Position: Q4 2024 in Review

Concourse Financial Group Securities sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 3 shares — an estimated $33 sold.

Concourse Financial Group Securities first reported a position in TVRD in Q4 2018 and held it in 23 quarters. The position peaked at $2K in Q3 2021. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

Concourse Financial Group Securities reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
Concourse Financial Group Securities sold 3 Tvardi Therapeutics shares in Q4 2024, an estimated $33.
Concourse Financial Group Securities first reported a position in Tvardi Therapeutics in Q4 2018 and held it in 23 quarters.
Concourse Financial Group Securities's Tvardi Therapeutics position peaked at $2K in Q3 2021.
43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on Concourse Financial Group Securities's 13F filing for Q4 2024, filed 13 Feb 2025.